Atavistik Bio
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $220M
Investors
- 5
About Atavistik Bio
Founded in 2021 and headquartered in Cambridge, US, Atavistik Bio, Inc. focuses on precision medicine through its proprietary drug discovery platform.00 mn.Atavistik Bio specializes in the discovery and development of precision allosteric small molecules aimed at addressing significant unmet medical needs across various diseases, particularly in precision oncology and rare diseases. The core offering is their proprietary drug discovery platform, known as the AMPS platform, which utilizes a combination of computational and experimental techniques to identify novel allosteric binding pockets. This innovative approach facilitates the design of small molecule therapeutics that can target previously intractable high-value targets.Atavistik Bio generates revenue through partnerships and collaborations with healthcare organizations and pharmaceutical companies that seek to utilize its advanced drug discovery capabilities. Revenue is typically derived from collaboration agreements allowing partners to access Atavistik's proprietary technologies and drug candidates, with potential income from milestone payments and royalties tied to the commercialization of developed therapeutics.In December 2023, Atavistik Bio, Inc. In March 2026, Atavistik Bio, Inc.
Who invested in Atavistik Bio
5 investors across 3 rounds
See all investors in Atavistik Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atavistik Bio
Who invested in Atavistik Bio?
Atavistik Bio has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atavistik Bio raised?
Atavistik Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Atavistik Bio last raise money?
Atavistik Bio's most recent round on record is a Series B, in Mar 2026.
What does Atavistik Bio do?
Founded in 2021 and headquartered in Cambridge, US, Atavistik Bio, Inc.
Where is Atavistik Bio headquartered?
Atavistik Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Atavistik Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atavistik Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Atavistik Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.